Fexofenadine's effects, alone and with alcohol, on actual driving and psychomotor performance

Journal of Allergy and Clinical Immunology

Volumn 101, Issue 3, 1998, Pages 306-311

  Vermeeren, Annemiek ^a   O'Hanlon, James F ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Alcohol interactions; Antihistamines; Car driving; Clemastine; Fexofenadine; Healthy volunteers; Psychomotor performance

Indexed keywords

FEXOFENADINE;

ADULT; ALCOHOL CONSUMPTION; ALLERGY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRIVING ABILITY; DRUG EFFECT; DRUG SAFETY; FEMALE; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE;

EID: 0031895422     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(98)70240-4     Document Type: Article

References (28)

1. Fexofenadine hydrochloride (MDL 16.455A). Investigational drug brochure. Edition no. 3. Kansas City (MO): Hoechst Marion Roussel, Inc.; 1995.
2. Lippert C, Ling J, Brown P, Burmaster S, Eller M, Cheng L, et al. Mass balance and pharmacokinetics of MDL 16.455A in healthy male volunteers. Pharm Res 1995;12:390.
3. Day JH, Briscoe MP, Welsh A, Smith J, Mason J. Onset of action, efficacy and safety of a single dose of 60 mg and 120 mg fexofenadine HC1 for ragweed (RW) allergy using controlled antigen exposure in an environmental exposure unit (EEU) [abstract]. J Allergy Clin Immunol 1996;97:434.
4. Bernstein D, Schoenwetter W, Nathan R, Storms W, Mason J. Fexofenadine: a new nonsedating antihistamine is effective in the treatment of seasonal allergic rhinitis [abstract]. J Allergy Clin Immunol 1996;97:435.
5. Tinkelman D, Falliers C, Bronsky E, Kaiser H, Mason J. Efficacy and safety of fexofenadine HC1 in fall seasonal allergic rhinitis [abstract]. J Allergy Clin Immunol 1996;97:435.
6. Vuurman EFPM, Uiterwijk MMC, Rosenzweig P, O'Hanlon JF. Effects of mizolastine and clemastine on actual driving and psychomotor performance in healthy volunteers. Eur J Clin Pharmacol 1994;47:253-9.
7. Jex HR, McDonnel JD, Phatak AV. Critical tracking task for manual control research. IEEE Transactions on Human Factors in Electronics 1966;HFE-7:138-45.
8. Mackworth NH. Researches on the measurement of human performance. HMSO Medical Research Council Special report no. 268. London: Her Majesty's Stationary Office; 1950.
9. O'Hanlon JF, Ramaekers JG. Antihistamine effects on actual driving performance in a standard test: a summary of Dutch experience, 1989-94. Allergy 1995;50:234-42.
10. O'Hanlon JF, Vermeeren A, Uiterwijk MMC, van Veggel LMA, Swijgman HF. Anxiolytics' effects on the actual driving performance of patients and healthy volunteers in a standardized test. Neuropsychobiology 1995;31:81-8.
11. Ramaekers JG, Uiterwijk MMC, O'Hanlon JF. Effects of loratadine and cetirizine on actual driving and psychometric test performance, and EEG during driving. Eur J Clin Pharmacol 1992;42:363-9.
12. Vuurman EFPM, Muntjewerff ND, Uiterwijk MMC, Van Veggel LMA, Crevoisier C, Haglund L, et al. Effects of mefloquine, alone and with alcohol, on psychomotor and driving performance. Eur J Clin Pharmacol 1996;50:475-82.
13. McRuer DT, Krendel ES. The human operator as a servo system element. J Franklin Inst 1959;267:381-403, 511-36.
14. McRuer DT, Jex HR. A review of quasi-linear pilot models. IEEE Transaction on Human Factors in Electronics 1967;8:231-6.
15. Koelega HS. Stimulant drugs and vigilance performance: a review. Psychopharmacology 1993;111:1-16.
16. Clarke CH, Nicholson AN. Performance studies with antihistamines. Br J Clin Pharmacol 1978;6:31-6.
17. Moskowitz H, Burns M. Effects of antihistamines on behavioral skills in driving. J Respir Dis 1988;8(Suppl):Sl-24.
18. Betts T, Kenwood C, Dalby G, Hull B, Wild J. A comparison of the effects of two nonsedating anti-histamines (terfenadine and cetirizine) on tests of CNS function including driving. J Psychopharmacol 1989;3/4:101-3.
19. Simons FER, Fraser TG, Reggin JD, Simons KJ. Comparison of the central nervous system effects produced by six Hl-receptor antagonists. Clin Exp Allergy 1996;26:1092-7.
20. Riedel WJ, Schoenmakers EAJM, O'Hanlon JF. Sedation and performance impairment with antihistamines. In: Kaline MA, editor. Management of allergy in the 1990s. Toronto, Canada: Hans Huber Publishers; 1989. p. 38-49.
21. Volkerts ER, van Willigenburg APP, van Laar MW, Maes RAA. Does cetirizine belong to the new generation of antihistamines? An investigation into its acute and subchronic effects on highway driving, psychometric test performance and daytime sleepiness. Hum Psychopharmacol 1992;7:227-38.
22. Ramaekers JG, O'Hanlon JF. Acrivastine, terfenadine and diphenhydramine effects on driving performance as a function of dose and time after dosing. Eur J Clin Pharmacol 1994;47:261-6.
23. Mattila MJ, Kuitunen T, Pletan Y. Lack of pharmacodynamic and pharmacokinetic interactions of the antihistamine ebastine with ethanol in healthy subjects. Eur J Clin Pharmacol 1992;43:179-84.
24. Brookhuis KA, de Vries G, de Waard D. Acute and subchronic effects of the Hl-histamine receptor antagonist ebastine in 10, 20 and 30 mg dose and triprolidine 10 mg on car driving performance. Br J Clin Pharmacol 1993;36:67-70.
25. Ling KH, Leeson GA, Burmaster SD, Hook RH, Reith MK, Cheng LK. Metabolism of terfenadine associated with CYP3A(4) activity in human hepatic microsomes. Drug Metab Dispos 1995;23:631-6.
26. Simons FER. Hl-receptor antagonists: comparative tolerability and safety. Drug Safety 1994;10:350-80.
27. Rose C, Quache IT, Llorens C, Schwartz JC. Relationship between occupation of cerebral Hl-receptors and sedative properties of antihistamines. Assessment in the case of terfenadine. Arzneimittelforschung 1982;32:1171-3.
28. Manning C, Gengo FM. Effects of drugs on human functioning: antihistamines. In: Streufert S, Gengo FM, editors. Effects of drugs on human functioning. Basel: Karger; 1993. p. 52-69.